While the identification of a BRCA pathogenic variant constitutes a clear benefit for probands and their relatives3,4, a proportion of at-risk families do not present pathogenic variants in BRCA1 or BRCA2 and their genetic risk of breast cancer remains unexplained. This evidence concerns the gene BRCA1 and breast cancer.